table of content
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnosis of Tumors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnosis of Tumors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnosis of Tumors Overall Market Size
2.1 Global Molecular Diagnosis of Tumors Market Size: 2023 VS 2030
2.2 Global Molecular Diagnosis of Tumors Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnosis of Tumors Players in Global Market
3.2 Top Global Molecular Diagnosis of Tumors Companies Ranked by Revenue
3.3 Global Molecular Diagnosis of Tumors Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnosis of Tumors Companies in Global Market, by Revenue in 2023
3.5 Global Companies Molecular Diagnosis of Tumors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnosis of Tumors Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnosis of Tumors Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnosis of Tumors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnosis of Tumors Market Size Markets, 2023 & 2030
4.1.2 NGS-Based
4.1.3 PCR-Based
4.2 By Type - Global Molecular Diagnosis of Tumors Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnosis of Tumors Revenue, 2019-2024
4.2.2 By Type - Global Molecular Diagnosis of Tumors Revenue, 2025-2030
4.2.3 By Type - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnosis of Tumors Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Others
5.2 By Application - Global Molecular Diagnosis of Tumors Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnosis of Tumors Revenue, 2019-2024
5.2.2 By Application - Global Molecular Diagnosis of Tumors Revenue, 2025-2030
5.2.3 By Application - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Molecular Diagnosis of Tumors Market Size, 2023 & 2030
6.2 By Region - Global Molecular Diagnosis of Tumors Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnosis of Tumors Revenue, 2019-2024
6.2.2 By Region - Global Molecular Diagnosis of Tumors Revenue, 2025-2030
6.2.3 By Region - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Molecular Diagnosis of Tumors Revenue, 2019-2030
6.3.2 US Molecular Diagnosis of Tumors Market Size, 2019-2030
6.3.3 Canada Molecular Diagnosis of Tumors Market Size, 2019-2030
6.3.4 Mexico Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnosis of Tumors Revenue, 2019-2030
6.4.2 Germany Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.3 France Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.4 U.K. Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.5 Italy Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.6 Russia Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.7 Nordic Countries Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.8 Benelux Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnosis of Tumors Revenue, 2019-2030
6.5.2 China Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.3 Japan Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.4 South Korea Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.5 Southeast Asia Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.6 India Molecular Diagnosis of Tumors Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Molecular Diagnosis of Tumors Revenue, 2019-2030
6.6.2 Brazil Molecular Diagnosis of Tumors Market Size, 2019-2030
6.6.3 Argentina Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnosis of Tumors Revenue, 2019-2030
6.7.2 Turkey Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7.3 Israel Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7.4 Saudi Arabia Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7.5 UAE Molecular Diagnosis of Tumors Market Size, 2019-2030
7 Molecular Diagnosis of Tumors Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Molecular Diagnosis of Tumors Major Product Offerings
7.1.4 Abbott Laboratories Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Roche Holding
7.2.1 Roche Holding Company Summary
7.2.2 Roche Holding Business Overview
7.2.3 Roche Holding Molecular Diagnosis of Tumors Major Product Offerings
7.2.4 Roche Holding Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.2.5 Roche Holding Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Molecular Diagnosis of Tumors Major Product Offerings
7.3.4 Thermo Fisher Scientific Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Company Summary
7.4.2 Danaher Corporation Business Overview
7.4.3 Danaher Corporation Molecular Diagnosis of Tumors Major Product Offerings
7.4.4 Danaher Corporation Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.4.5 Danaher Corporation Key News & Latest Developments
7.5 Veracyte
7.5.1 Veracyte Company Summary
7.5.2 Veracyte Business Overview
7.5.3 Veracyte Molecular Diagnosis of Tumors Major Product Offerings
7.5.4 Veracyte Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.5.5 Veracyte Key News & Latest Developments
7.6 TBG Diagnostics
7.6.1 TBG Diagnostics Company Summary
7.6.2 TBG Diagnostics Business Overview
7.6.3 TBG Diagnostics Molecular Diagnosis of Tumors Major Product Offerings
7.6.4 TBG Diagnostics Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.6.5 TBG Diagnostics Key News & Latest Developments
7.7 Agilient Technologies
7.7.1 Agilient Technologies Company Summary
7.7.2 Agilient Technologies Business Overview
7.7.3 Agilient Technologies Molecular Diagnosis of Tumors Major Product Offerings
7.7.4 Agilient Technologies Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.7.5 Agilient Technologies Key News & Latest Developments
7.8 Illumina
7.8.1 Illumina Company Summary
7.8.2 Illumina Business Overview
7.8.3 Illumina Molecular Diagnosis of Tumors Major Product Offerings
7.8.4 Illumina Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.8.5 Illumina Key News & Latest Developments
7.9 Genecast
7.9.1 Genecast Company Summary
7.9.2 Genecast Business Overview
7.9.3 Genecast Molecular Diagnosis of Tumors Major Product Offerings
7.9.4 Genecast Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.9.5 Genecast Key News & Latest Developments
7.10 Burning Rock Biotech
7.10.1 Burning Rock Biotech Company Summary
7.10.2 Burning Rock Biotech Business Overview
7.10.3 Burning Rock Biotech Molecular Diagnosis of Tumors Major Product Offerings
7.10.4 Burning Rock Biotech Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.10.5 Burning Rock Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
